Obsidian Therapeutics' Series A Round

Obsidian Therapeutics raised a round of funding on December 06, 2017.

Obsidian Therapeutics is developing next-generation cell and gene therapies with pharmacologic operating systems. It creates adoptive cell therapies with new functions that are under control of the tr…

Articles about Obsidian Therapeutics' Series A Round: